tiprankstipranks
Trending News
More News >
IBI Investment House Ltd. (IL:IBI)
:IBI
Israel Market

Ibi Inv House (IBI) AI Stock Analysis

Compare
1 Followers

Top Page

IL:IBI

Ibi Inv House

(IBI)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
33,141.00
▲(12.00% Upside)
Ibi Inv House's strong financial performance and positive technical indicators are the primary drivers of its overall stock score. While the valuation suggests the stock may be expensive, the solid dividend yield offers some compensation. The lack of earnings call data and corporate events does not impact the score due to their exclusion.
Positive Factors
Revenue Growth
Sustained revenue growth indicates robust market demand and effective business strategies, enhancing long-term financial stability.
Profitability Margins
Strong profitability margins reflect efficient cost management and pricing power, supporting long-term earnings potential.
Cash Flow Generation
Robust cash flow generation enhances financial flexibility, enabling investment in growth opportunities and debt management.
Negative Factors
Earnings Decline
Declining earnings per share can signal challenges in maintaining profitability, potentially impacting investor confidence and valuation.
Leverage Concerns
While manageable, increased leverage could limit financial flexibility and increase risk if not carefully managed.
Lack of Earnings Call Data
Absence of earnings call data may hinder transparency and investor communication, affecting market perception and trust.

Ibi Inv House (IBI) vs. iShares MSCI Israel ETF (EIS)

Ibi Inv House Business Overview & Revenue Model

Company DescriptionIbi Inv House (IBI) is a diversified investment firm specializing in asset management, private equity, and venture capital. The company operates across various sectors, including technology, healthcare, real estate, and renewable energy, providing a comprehensive range of financial services. IBI focuses on identifying high-potential investment opportunities and offers tailored financial solutions to both institutional and retail clients, including fund management, advisory services, and wealth management.
How the Company Makes MoneyIbi Inv House generates revenue primarily through management fees charged on the assets under management (AUM) in its various investment funds. Additionally, the company earns performance fees based on the profits generated from its investments, particularly in private equity and venture capital. Key revenue streams also include advisory fees from corporate clients seeking strategic insights and investment guidance. IBI has established significant partnerships with financial institutions and other investment firms, enhancing its market reach and investment capabilities, which contribute to its overall earnings. Furthermore, IBI capitalizes on investment exit strategies such as IPOs and mergers and acquisitions, which provide substantial returns and boost its revenue.

Ibi Inv House Financial Statement Overview

Summary
Ibi Inv House demonstrates strong profitability with high margins, but faces challenges due to a significant revenue decline and negative free cash flow growth in the TTM. The company maintains a balanced leverage position and a solid equity base.
Income Statement
85
Very Positive
Ibi Inv House shows strong profitability with a high gross profit margin of 95.99% and a net profit margin of 23.57% in the TTM. However, the company experienced a significant revenue decline of 32.45% in the TTM, which is a concern. Despite this, EBIT and EBITDA margins remain robust at 54.86% and 66.30%, respectively, indicating efficient operations.
Balance Sheet
78
Positive
The company maintains a moderate debt-to-equity ratio of 0.35, suggesting a balanced approach to leverage. Return on equity is healthy at 15.58%, reflecting effective use of equity to generate profits. The equity ratio stands at 44.08%, indicating a solid equity base relative to total assets.
Cash Flow
80
Positive
Cash flow analysis reveals a decline in free cash flow growth by 30.70% in the TTM, which is concerning. The operating cash flow to net income ratio is 0.34, indicating moderate cash generation relative to net income. The free cash flow to net income ratio is 0.78, showing decent cash conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue693.61M1.04B791.55M660.61M548.65M435.79M
Gross Profit671.10M696.21M511.24M417.09M357.00M279.51M
EBITDA407.72M368.28M281.08M212.29M227.69M150.50M
Net Income146.12M178.14M156.46M90.76M139.58M81.94M
Balance Sheet
Total Assets2.09B1.85B1.27B1.08B1.13B1.02B
Cash, Cash Equivalents and Short-Term Investments603.89M519.23M453.00M246.53M547.09M530.66M
Total Debt303.18M243.90M201.26M154.42M334.90M197.25M
Total Liabilities972.93M750.27M539.07M399.48M521.39M469.80M
Stockholders Equity891.39M899.76M686.62M640.44M575.47M522.10M
Cash Flow
Free Cash Flow209.21M218.35M207.56M45.23M190.60M68.70M
Operating Cash Flow244.07M249.28M269.65M61.11M197.55M79.24M
Investing Cash Flow-117.41M-97.88M-269.38M-44.08M36.90M-83.84M
Financing Cash Flow-70.00M-141.00K-37.48M-80.76M-196.36M24.85M

Ibi Inv House Technical Analysis

Technical Analysis Sentiment
Positive
Last Price29590.00
Price Trends
50DMA
25202.42
Positive
100DMA
24503.16
Positive
200DMA
23218.42
Positive
Market Momentum
MACD
1211.21
Positive
RSI
69.58
Neutral
STOCH
84.15
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Positive. The current price of 29590 is above the 20-day moving average (MA) of 28133.05, above the 50-day MA of 25202.42, and above the 200-day MA of 23218.42, indicating a bullish trend. The MACD of 1211.21 indicates Positive momentum. The RSI at 69.58 is Neutral, neither overbought nor oversold. The STOCH value of 84.15 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:IBI.

Ibi Inv House Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
1.40B13.126.09%687.69%21.73%
74
Outperform
4.14B27.833.93%46.14%-17.83%
69
Neutral
3.95B11.495.95%19.48%53.61%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:IBI
Ibi Inv House
29,900.00
14,739.35
97.22%
IL:FBRT
Fms
21,240.00
8,342.68
64.69%
IL:LAPD
Lapidoth Cap.
10,140.00
3,781.62
59.47%
IL:IDIN
Idi Insur
26,750.00
14,363.11
115.95%
IL:JBNK
Jerusalem
2,336.00
662.93
39.62%
IL:ATRY
Atreyu Cap
9,484.00
2,775.00
41.36%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 18, 2025